{
 "drug": "Hydroxocobalamin Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "11/04/2024",
 "dayN": 659,
 "cat": "Other",
 "companies": [
  "Teva Pharmaceuticals USA, Inc.",
  "BTG International Inc."
 ],
 "reasons": [
  "Other"
 ],
 "records": [
  {
   "update_type": "Revised",
   "initial_posting_date": "11/04/2024",
   "package_ndc": "0591-2888-30",
   "generic_name": "Hydroxocobalamin Injection",
   "contact_info": "800-545-8800",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: September 2026",
   "openfda": {
    "application_number": [
     "ANDA085998"
    ],
    "brand_name": [
     "HYDROXOCOBALAMIN"
    ],
    "generic_name": [
     "HYDROXOCOBALAMIN"
    ],
    "manufacturer_name": [
     "Actavis Pharma, Inc."
    ],
    "product_ndc": [
     "0591-2888"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR"
    ],
    "substance_name": [
     "HYDROXOCOBALAMIN ACETATE"
    ],
    "rxcui": [
     "317106"
    ],
    "spl_id": [
     "c47477bf-6413-4699-ab77-c5441a9d1557"
    ],
    "spl_set_id": [
     "a3087a39-f218-4f16-a1e7-17c39bb2eb69"
    ],
    "package_ndc": [
     "0591-2888-30"
    ],
    "unii": [
     "S535M27N3Q"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Other"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/04/2024",
   "package_ndc": "50633-310-11",
   "generic_name": "Hydroxocobalamin Injection",
   "related_info_link": "https://www.fda.gov/media/185400/download",
   "contact_info": "1 877 377 3784",
   "availability": "Limited Availability",
   "related_info": "Cyanokit is available to order. To address the drug shortage, BTG International Inc (a SERB Pharmaceuticals company) coordinated with the U.S. Food and Drug Administration (FDA) to make the following impacted batches available to U.S. patients during this period of shortage.",
   "openfda": {
    "application_number": [
     "NDA022041"
    ],
    "brand_name": [
     "CYANOKIT"
    ],
    "generic_name": [
     "HYDROXOCOBALAMIN"
    ],
    "manufacturer_name": [
     "BTG INTERNATIONAL INC."
    ],
    "product_ndc": [
     "50633-310"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HYDROXOCOBALAMIN"
    ],
    "rxcui": [
     "700496",
     "700499"
    ],
    "spl_id": [
     "9955075c-c059-4b63-b387-e98ef13e60dc"
    ],
    "spl_set_id": [
     "d56fcc8d-bd64-46ab-b0c0-2124bd745a6b"
    ],
    "package_ndc": [
     "50633-310-11"
    ],
    "nui": [
     "N0000175429"
    ],
    "pharm_class_epc": [
     "Antidote [EPC]"
    ],
    "unii": [
     "Q40X8H422O"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Other"
   ],
   "dosage_form": "Injection",
   "presentation": "Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11)",
   "company_name": "BTG International Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  }
 ]
}